Loading clinical trials...
Loading clinical trials...
In this study, high-throughput screening and multi-omics (transcriptomics and proteomics) joint analysis technology will be employed to explore potential CTE/TES biomarkers (RNA and protein) in blood ...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Tianjin Medical University
Collaborators
NCT03724136 · Alzheimer Disease, Alzheimer Dementia, and more
NCT05490576 · Chronic Traumatic Encephalopathy, Traumatic Encephalopathy, and more
NCT04489082 · Refractory Depression, Anxiety Disorders, and more
NCT04311281 · Suspected Chronic Traumatic Encephalopathy (CTE) or Traumatic Encephalopathy Syndrome (TES), Suspected Alzheimer's Disease (AD)
NCT01891383 · Dementia, Traumatic Brain Injury (TBI), and more
Tianjin Medical University General Hospital
Tianjin, Tianjin Municipality
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions